Search

everythinglearnresearchcommunity

for

Search:↓

Equisetum debile extract, especially the ethyl acetate type, may be a promising natural ingredient for anti-hair loss products.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Social isolation makes rats more sensitive to alcohol's effects on the brain.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Neurosteroids from glia cells help control seizure development in epilepsy.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Neurosteroid production in the brain may delay seizure onset.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Betamethasone is more effective for hair regrowth than latanoprost but has more side effects.

The FDA rejected a testosterone drug again due to safety concerns.

Neurosteroids in the brain can increase or decrease seizure risk in mice.

DPCP may be safe for treating alopecia during pregnancy, but more research is needed.

Testosterone pellet therapy may better address hormone imbalances in aging by focusing on local hormone production and symptom relief.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

CG2001 is safe and well-tolerated for treating hair loss in men.

High doses of cyproterone acetate are linked to an increased risk of developing meningioma.

Patients need better information about the risks of long-term steroid use.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Neuroactive steroids may affect the risk and treatment of alcohol use disorders.

Both treatments improved hair quality and thickness equally, with mild side effects.